跳至主要内容
临床试验/NCT07385508
NCT07385508招募中不适用

Neurorehabilitation in Patients With Disorders of Consciousness: Multidimensional Ambispective Study on the Impact of Single and Combined Approaches

IRCCS Centro Neurolesi Bonino Pulejo1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2026年1月16日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
140
试验地点
1
主要终点
Level of consciousness

研究概览

简要总结

Disorders of consciousness (DOC), such as the vegetative state/unresponsive wakefulness syndrome (VS/UWS) and the minimally conscious state (MCS), represent severe clinical conditions arising from acquired brain injury (ABI), exerting a profound impact on patients, caregivers, and healthcare systems. The clinical heterogeneity, diagnostic challenges, and paucity of robust evidence on the comparative efficacy of rehabilitation interventions underscore the need for a deeper understanding of the underlying neurophysiological, cognitive, and biological mechanisms involved in consciousness recovery. This monocentric ambispective observational study aims to investigate the effects of advanced neurorehabilitation treatments-including multimodal sensory stimulation, non-invasive neuromodulation via transcranial magnetic stimulation (TMS) or transcranial direct current stimulation (tDCS), and the use of augmentative and alternative communication (AAC) devices with eye-tracking-on various facets of residual consciousness in patients diagnosed with DOC admitted to the Neurorehabilitation Unit of the IRCCS Centro Neurolesi "Bonino Pulejo" in Messina.

The study design encompasses the collection of clinical and rehabilitation data from hospitalized patients undergoing treatment, both retrospectively and prospectively. Specifically, data from patients admitted and treated in the 36 months preceding study initiation, as well as those admitted and treated in the subsequent 36 months, will be included. Upon data collection, participants will be classified a posteriori as "responders" or "non-responders" based on whether they meet at least one of the following criteria: (I) an increase of ≥3 points on the Coma Recovery Scale-Revised (CRS-R) from baseline or a clinically relevant state transition (e.g., VS/UWS → MCS; MCS → emergence from MCS [EMCS]); (II) an increase of ≥10 points on the Functional Independence Measure (FIM) or ≥0.5 standard deviations (SD) from baseline; (III) an increase of ≥10 points on the Barthel Index or ≥0.5 SD from baseline.

The primary objective is to estimate the proportion of responders and non-responders at the end of training or hospitalization. Secondary objectives include identifying variables predictive of treatment response at the end of intervention (training type/modality, aetiology, demographic factors, comorbidities), quantifying the dose-response gradient (number of sessions/session duration versus response probability), and assessing changes in neurophysiological, physiological, and biological parameters collected during hospitalization (neuroimaging examinations, neurofilament light chain [NfL] assays, EEG/event-related potentials [ERP], skin conductance response, heart rate frequency and variability, and oculomotor activity).

Data will be analysed using descriptive statistics appropriate to variable distributions. The primary endpoint, defined as the proportion of responders at the end of training/hospitalization, will be evaluated using logistic regression models in an as-treated approach, reporting odds ratios and marginal estimates (risk ratios and absolute risk differences) with 95% confidence intervals (CI). Confounding will be addressed through multivariable adjustment and propensity score-based methods (inverse probability of treatment weighting [IPTW]/overlap weighting). Continuous secondary outcomes will be analysed with linear models or linear mixed-effects models for repeated measures. Dose-response relationships will be explored, alongside sensitivity and subgroup analyses. All analyses will be performed using R software (version 4.4.2), employing two-sided tests with a significance level of α=0.05. The study will be conducted in accordance with the Declaration of Helsinki and Good Clinical Practice (GCP) guidelines.

详细描述

The protocol is grounded in the increasing survival of patients with severe acquired brain injury due to advances in intensive care, which has led to a growing population with prolonged DOC and substantial socio-economic burden, including lifetime care costs exceeding one million euros in some estimates. Within this context, neurorehabilitation is conceptualized as a multidimensional process targeting arousal, awareness, motor and cognitive function, communication, and autonomy, and the study posits that combining structured sensory stimulation with non-invasive brain stimulation and technologically assisted communication can enhance residual brain plasticity and functional recovery beyond that achieved with standard conservative approaches. The rationale emphasizes that DOC assessment based solely on overt behavioural responses is vulnerable to misclassification, underscoring the importance of integrating advanced neurophysiological, neuroimaging, and biological markers to more accurately quantify residual consciousness and track treatment-related changes.

From an intervention standpoint, the protocol details a spectrum of non-invasive treatments: multimodal SS consists of repeated, simple, emotionally salient, or autobiographical stimuli delivered through auditory, visual, tactile, and olfactory channels, which can be administered singly or in combination to enhance arousal and behavioural responsiveness. AAC systems with eye-tracking enable "active" sensory stimulation by pairing visual and auditory stimuli with graded tasks whose performance is inferred from oculomotor behaviour, thus offering both diagnostic information about cognitive abilities and opportunities for structured engagement with the environment. tDCS is introduced as a low-intensity direct current technique applied repeatedly to modulate resting-state membrane polarization and network connectivity, with advantages over repetitive TMS in terms of safety, logistical simplicity, and potential for inducing longer-lasting neuromodulatory effects; TMS is framed as a complementary, focal method of electromagnetic stimulation targeting cortical regions relevant for consciousness.

The protocol allocates substantial attention to biomarkers and mechanistic readouts, particularly the role of neurofilament proteins as indicators of axonal integrity and neuroaxonal damage. Neurofilament light chain (NfL), owing to its relative specificity compared with traditional markers such as neuron-specific enolase, S-100B, and glial fibrillary acidic protein, is incorporated as a key biochemical outcome, measured from venous blood samples obtained in conjunction with routine clinical draws to enable minimally invasive longitudinal monitoring. The study aims not only to explore NfL as a prognostic indicator of long-term neurological outcome but also as a dynamic marker of treatment impact, hypothesizing that responders will show reductions in serum NfL consistent with attenuated ongoing axonal injury.

Neurophysiological recording protocols are designed to capture both spontaneous and stimulus-locked brain activity as correlates of consciousness and plasticity. EEG and high-density EEG acquisitions are typically performed at the bedside under standardized environmental conditions (moderated lighting, potential use of eye masks to reduce artefacts), and processing pipelines include channel-wise normalization, high-pass filtering to remove slow artefacts such as respiration, and low-pass filtering to suppress high-frequency noise. Beyond conventional spectral analyses, the study focuses on event-related potentials derived from paradigms such as auditory oddball stimulation, in which infrequent deviant sounds interspersed among frequent standard tones elicit P300 responses that have been shown to differentiate between diagnostic subgroups and may index residual conscious processing of salient stimuli, including responses to one's own name.

Autonomic and oculomotor measures complement EEG as additional windows onto arousal and information processing. Cardiac monitoring yields indices such as heart rate and heart rate variability, which can reflect autonomic balance and reactivity, while skin conductance responses quantify sympathetic activation in response to sensory events. Eye-tracking metrics captured through AAC devices include fixation duration and count, saccadic latency, amplitude and velocity, gaze accuracy, and distributions across pre-defined areas of interest, enabling fine-grained characterization of visual exploration and potential signs of goal-directed attention or command following in patients with severely limited motor output.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of VS/MCS following ABI, according to clinical and neuroradiological findings.
  • Age between 18 and 90 years.
  • Adequate pulmonary gas exchange function (PaO₂ / FiO₂ ratio ≥ 250).
  • Stable haemodynamic profile (absence of significant arterial variations in mean arterial pressure and/or heart rate).

排除标准

  • Diagnosis of DOC due to non-structural aetiopathogenesis.
  • Having previously undergone multiple rehabilitation cycles
  • Being affected by deafness and/or blindness
  • Having unstable intracranial pressure values
  • Having cerebral perfusion values below 60 mmHg
  • Having other concomitant medical conditions that could interfere with the rehabilitation

研究组 & 干预措施

Responders

A patient is classified as a "responder" if they meet at least one of the following criteria relative to baseline:

I. An increase of ≥3 points on the Coma Recovery Scale-Revised (CRS-R) or a clinically relevant state transition (e.g., VS/UWS → MCS; MCS → emergence from MCS [EMCS]).

II. An increase of ≥10 points on the Functional Independence Measure (FIM) or ≥0.5 standard deviations (SD) from baseline.

III. An increase of ≥10 points on the Barthel Index or ≥0.5 SD from baseline.

干预措施: Multidisciplinary neurorehabilitation (Device)

结局指标

主要结局

Level of consciousness

时间窗: From admission to 36 months or eventual discharge

CRS-R

次要结局

  • Neurorehabilitative training modalities(From baseline to 36 months/discharge)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Davide Cardile

Psychologist

IRCCS Centro Neurolesi Bonino Pulejo

研究点 (1)

Loading locations...

相似试验